-
of Twente and Wageningen, to detect RNA biomarkers with CRISPR-Cas13. This technology is ultra-sensative and may revolutionize ‘point of care ‘cancer diagnostics. You will work with state-of-the-art
-
on the cytokine responses of macrophages; Next to cell culture experiments, you will use and analyze state-of-the-art approaches such as RNA-sequencing and ChIP-sequencing analysis; Translate your findings
-
on sequenicng of cell-free nucleaic acids shed by tumors into circulation may forecast which individual patient is likley to respond to therapy. You will work with state-of-the-art sequencing technologies
-
should possess knowledge of state-of-the-art computational methods related to spatial data analysis, such as multimodal deep learning, self-supervised computer vision, multiple instance learning, panoptic
-
methodological development and implementation, and aims to increase accessibility of state of the art methods to a wide audience. Objectives include methodological developments and implementations that facilitate
-
of macrophages; Next to cell culture experiments, you will use and analyze state-of-the-art approaches such as RNA-sequencing and ChIP-sequencing analysis; Translate your findings to disease models; Align
-
)metabolic eye disorder. Based on disease pathology, patient’s needs, ethical considerations, therapeutic developmental time lines, and current state of the art of gene therapy, we recently posed that the most